A novel class of small molecule inhibitors of Hsp90

Fang Yi1, Lynne Regan

  • 1Department of Molecular Biophysics & Biochemistry, Yale University, 266 Whitney Avenue, New Haven, Connecticut 06520, USA.

ACS Chemical Biology
|September 13, 2008
PubMed

Insights

Researchers identified compounds that disrupt heat-shock protein 90 (Hsp90) interactions with its cochaperone HOP. This novel approach inhibits cancer cell growth by reducing Hsp90-dependent proteins like HER2, leading to cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Unregulated cellular proliferation drives cancer, often involving growth-promoting proteins dependent on heat-shock protein 90 (Hsp90).
  • Hsp90 is crucial for the folding and maturation of these client proteins, making it a potential therapeutic target for cancer treatment.
  • Existing strategies involve inhibiting Hsp90 directly with ATP analogs like 17-AAG.

Purpose of the Study:

  • To explore a novel strategy for inhibiting Hsp90 by disrupting its interaction with the cochaperone Hsp organizing protein (HOP).
  • To identify small molecules that inhibit the Hsp90-HOP interaction using a high-throughput screening method.
  • To evaluate the in vitro and in vivo efficacy of these identified compounds as anticancer agents.

Main Methods:

  • Utilized AlphaScreen technology for a high-throughput in vitro screen to identify compounds inhibiting the Hsp90-HOP interaction.
  • Tested the identified compounds for their ability to decrease Hsp90-dependent client proteins in human breast cancer cell lines.
  • Assessed the impact of compound treatment on cancer cell viability and proliferation.

Main Results:

  • Successfully identified compounds that inhibit the Hsp90-HOP interaction in vitro.
  • Demonstrated that these compounds are active in vivo, reducing levels of the Hsp90 client protein HER2 in BT474 and SKBR3 breast cancer cells.
  • Observed associated cancer cell death following treatment, indicating therapeutic potential.

Conclusions:

  • Disrupting the Hsp90-HOP interaction represents a viable and distinct strategy for Hsp90 inhibition in cancer therapy.
  • The identified compounds show promise as novel anticancer agents targeting Hsp90-dependent pathways.
  • This approach offers a potentially broader applicability compared to direct Hsp90 active-site inhibition.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...